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Changes in carotid plaque echomorphology with
time since a neurologic event
David A. Russell, MRCS(Ed), S. Mandika Wijeyaratne, MS, FRCS, and Michael J. Gough, ChM, FRCS,
Leeds, United Kingdom
Purpose: Symptomatic carotid plaques are characterized by reduced fibrous tissue content, increased lipid content,
intraplaque hemorrhage, and cap rupture. This confers an increased stroke risk. Plaque remodelling reduces this risk,
however, and this study has evaluated differences in echomorphology at varying times after a neurologic event.
Methods: Gray scale medians (GSM  interquartile ranges) were measured using the best single longitudinal (SLV) and
multiple cross-sectional views (MCSV; transverse views, 5-mm intervals throughout plaque) on B-mode ultrasound
images of 61 carotid plaques (70% to 99%) causing symptoms <30 (n  20), 31 to 90 (n  10), 91 to 180 (n  16), or
>180 days (n 15). The results were compared with those in 47 asymptomatic plaques. Plaque echolucency (SLV-GSM,
MCSVmin-GSM [cross-sectional image with lowest GSM]) and heterogeneity (MCSVmaxmin-GSM [highest minus
lowest GSM of cross-sectional views]) were determined.
Results: In symptomatic plaques, echolucency was maximal<30 days of the presenting neurologic event (SLV-GSM, P
.009; MCSVmin-GSM, P  .004). Although this diminished between 31 to 90 days, MCSV measurements in particular
suggested increased echolucency (P  .042 at >180 days) and continuing heterogeneity (P  .01 at 91 to 180 days)
beyond that time.
Conclusions: Plaque echolucency was maximal <30 days of a neurologic event but diminished after 1 to 3 months,
suggesting remodelling of unstable plaques. Continued features of increased echolucency and heterogeneity >91 days,
however, suggests an increased stroke risk in these patients compared with that of the general population. (J Vasc Surg
2007;45:367-72.)
Clinical Relevance: This cross-sectional study has demonstrated interesting differences in gray scale median plaque
echomorphology with time after the initial neurologic symptom in patients with symptomatic carotid disease. The results
raise some important questions with respect to identifying currently asymptomatic patients who might be at greatest risk
of a neurologic event and add fuel to the current debate relating to the relative benefits of either carotid endarterectomy
or carotid angioplasty and stenting in patients with recent symptoms.After a transient ischemic attack, the risk of stroke from
a recently symptomatic carotid plaque is maximal immedi-
ately, reducing by half after 1 year, and returning to base-
line 2 to 3 years after the initial symptom.1-3 Thus, ather-
omatous plaques are dynamic structures undergoing
continuous remodelling. Histologic studies of excised ca-
rotid atherectomy specimens have shown that morphologic
features, including a large lipid or necrotic core,4 particu-
larly when located close to the luminal surface5; fibrous cap
disruption,6 intraplaque hemorrhage,7,8 and surface ulcer-
ation,9 occur more frequently in recently symptomatic
plaques.
The morphologic changes associated with plaque insta-
bility have been assessed using single longitudinal view
(SLV) B-mode ultrasound imaging.10,11 Previous work
from our unit, however, has suggested that computer-
assisted multiple cross-sectional view echomorphology
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these changes.12
The natural history of plaque remodelling after a
neurologic event remains unknown. Although both the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET) and European Carotid Surgery Trial
(ECST) used a cutoff of 180 days since symptoms as the
therapeutic window for carotid endarterectomy, this was a
somewhat arbitrary decision. Indeed, subanalysis from
NASCET suggests continued benefit to surgery in sub-
groups of patients beyond this time period.13 Thus, the aim
of this study was to assess plaque echomorphology for all
70% to 99% carotid stenoses in patients undergoing carotid
endarterectomy in our unit to evaluate differences in
echolucency and heterogeneity at varying times after the
presenting neurologic event.
METHODS
A total of 108 consecutive carotid bifurcation plaques
causing 70% to 99% stenosis were studied in 94 patients (60
men, 34 women) referred for consideration of carotid
endarterectomy. Informed consent was obtained, and the
study was approved by the Ethics Committee of the Leeds
Teaching Hospitals NHS Trust.
A detailed neurologic history and examination were
recorded, with symptoms classified as amaurosis fugax,
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visual loss lasting1 hour; transient ischemic attack (TIA),
defined as sudden focal neurologic deficit lasting 24
hours with no other apparent cause; or stroke, defined
similarly to TIA but with symptoms lasting 24 hours.
Risk factors for vascular disease and medications were doc-
umented.
Cerebral hemorrhage and lacunar infarcts were ex-
cluded in patients with stroke using cerebral computed
tomography (CT) imaging. Also excluded were patients
with potential cardioembolic sources for symptoms, such as
concomitant cardiac arrhythmia on electrocardiogram or
24 hour Holter monitoring; or atrial thrombus or septal
defect on echocardiography. Twelve plaques (6 symptom-
atic, 6 asymptomatic) were excluded because acoustic shad-
owing resulted in inadequate B-mode information.
Ultrasound protocol. The percentage of carotid ste-
nosis was determined using duplex criteria for detecting
70% stenoses, validated within our unit, including inter-
nal carotid artery (ICA) peak systolic velocity (PSV-ICA
180 cm/s), end-diastolic velocity (EDV-ICA 80 cm/s),
and ratio of peak systolic velocity in the ICA and common
carotid artery (CCA) [PSV-ICA/CCA 4).14 A subgroup
with 80% to 99% stenosis were also identified (PSV-ICA
250 cm/s; EDV-ICA 100 cm/s).
Gray scale median (GSM) assessment of each plaque was
performed using a previously described method.12 Briefly,
patients were scanned by one of two ultrasonographers
(blinded to the clinical details) using a high-resolution scan-
ner (Acuson 128 XP10, Siemens, Munich, Germany) and a
5-MHz to 7-MHz multifrequency linear array probe. B-
mode settings were fixed throughout the study. The most
informative SLV (image with maximum plaque area) of the
plaque was obtained using color duplex and the image
“frozen.”
To determine plaque GSM by the technique of multi-
ple cross-sectional imaging, the carotid bifurcation was
located with an axial sweep of the neck, and transverse color
flow images were obtained at 5-mm intervals from this
point throughout the length of the plaque for a total of five
to eight multiple cross-sectional views (MCSV) per plaque.
After freezing each color image, the color-off facility of the
scanner was used to obtain the gray scale image of each
view. These images were digitized in bitmap format by a
commercially available video grabber (Matrox Marvel
G400 AGP, Dorval, Montréal, Canada) and downloaded
to a computer.
Images were normalized with computer software
(MATLAB 5.3, The MathWorks, Natick, Mass), using two
reference points (blood and adventitia) to a set gray scale
from 0 (black) to 255 (white). The GSM for each image
was then determined. Although the SLV-GSM provides a
single, selected measure of global plaque echolucency,
MCSV analysis allows identification of the transverse image
with the lowest GSM (MCSV-GSMmin) reflecting maximal
focal echolucency. Further, the difference between maxi-
mum and minimum GSM (MCSV-GSMmax–min) in the
transverse images assesses plaque heterogeneity, which can-not be quantified with SLV imaging. We have previously
published satisfactory correlations for intraobserver and
interobserver error for this technique.12
Patients were divided into five groups for analysis accord-
ing the most recent neurologic event: symptoms 30 days;
symptoms from 31 to 90 days; symptoms from 91 to 180
days; symptoms180 days previously; and asymptomatic.
Histology protocol. Endarterectomy was performed
using a modified technique to yield an intact plaque,14
under either local or general anesthesia. Transverse sections
were made at 4-mm intervals proximal and distal to the
carotid bifurcation. They were placed in 4% paraformalde-
hyde solution for 24 hours and then decalcified in ethyl-
enediamine tetraacetic acid (EDTA) for 2 weeks before
being embedded in paraffin. Sections (5 m) from each
paraffin block were stained with hematoxylin and eosin, van
Gieson, and Sirius red, and reported by a senior cardiovas-
cular pathologist blinded to clinical details.
Plaques with rupture or cap thinning were designated
unstable. Plaque rupture was defined as disruption of the
cap with direct communication between the lumen and
lipid core. Cap thinning was defined by the absence of
collagen or elastin tissue within the entire cap on at least
one section but usually on several sections throughout the
plaque. Plaques without either of these features were des-
ignated stable.
Statistical analysis. The 2 test was used to determine
differences in proportions. The Kruskal-Wallis test com-
Table I. Demographic factors and neurologic symptoms
in study patients
N
Sex
(M/F)
Age (years)
median (range) Symptoms*
Symptomatic
30 days 20 12:8 66.5 (46-83) 16:4
31-90 days 10 6:4 72.5 (54-87) 7:3
91-180 days 16 12:4 74.5 (60-80) 8:8
180 days 15 13:2 69 (52-86) 10:5
Asymptomatic 43 24:19 72 (48-86)
*Hemispheric/amaurosis fugax ratio.
Table II. Ipsilateral percentage of internal carotid artery
stenosis in study patients
Patients
(n)
Stenosis
70%-79%
n (%)
80%-89%
n (%)
90%-99%
n (%)
Symptoms
30 days 20 6 (30) 6 (30) 8 (40)
31-90 days 10 3 (30) 4 (40) 3 (30)
91-180 days 16 5 (31) 8 (50) 3 (19)
180 days 15 4 (27) 7 (47) 4 (26)
Asymptomatic 47 12 (26) 18 (38) 17 (36)
P* .99 .77 .66
*Differences between all groups; 2.pared age between groups. The one-sample Kolmogorov
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thus the Mann-Whitney U test was used for comparative
analysis. P .05 was considered significant. Statistical tests
were performed using SPSS 11.0 (SPSS Inc, Chicago, Ill)
computer software.
RESULTS
Of 108 consecutive 70% to 99% carotid stenoses, 61
had caused symptoms 30 (n  20), 31 to 90 (n  10),
91to 180 (n 16) or180 days (n 15) earlier. A further
47 asymptomatic plaques were also identified, including 24
asymptomatic bruits identified before coronary artery by-
pass grafting, seven bilateral; 11 contralateral to symptom-
atic occlusion, and 12 contralateral to symptomatic high-
grade stenoses.
There were no demographic differences among the
symptomatic groups, and the ratio of hemispheric TIA and
stoke to amaurosis fugax was similar in each of these (Table I).
Similarly, no difference was found in the percentage of
ipsilateral stenosis between groups (P  .69; Table II).
There were more current smokers amongst the asymptom-
atic patients (P  .01; Table III).
Echomorphology results. The median GSM inter-
quartile range for each group is summarized in Table IV.
Global plaque echolucency (SLV-GSM)wasmaximal in the
most recently symptomatic plaques, with a stepwise return
to near asymptomatic levels by 91 to 180 days, suggesting
remodelling of the plaque. There was, however, a trend
towards increasing echolucency in plaques remaining
asymptomatic for 180 days (Fig 1). This pattern was
accentuated when assessing focal plaque echolucency
Table III. Risk factors for vascular disease in study patien
Patients (n) Hypertension n (%) Diab
Symptoms
30 days 20 13 (65)
31-90 days 10 6 (60)
91-180 days 16 11 (69)
180 days 15 11 (73)
Asymptomatic 43 29 (67)
P* 0.78 0.97
*Difference between all groups; 2.
Table IV. Median value for gray scale median and interqu
N SLV-GSM P*
Symptoms
30 days 20 13.1 (6.4-35.3) .009
31-90 days 10 22.0 (10.5-45.0) .43
91-180 days 16 33.0 (10.0-48.0) .77
180 days 15 20.0 (3.0-39.0) .07
Asymptomatic 43 32.5 (19.0-56.3) —
SLV, Single longitudinal view; GSM, gray scale median;MCSV,multiple cro
lowest gray scale median of cross-sectional views.
*P vs asymptomatic; Mann-Whitney.(MCSV-GSMmin), with GSM never returning to asymp-tomatic values (Fig 2). Plaque heterogeneity was increased
in all symptomatic plaque groups vs asymptomatic plaques,
reaching significance only in the 91 to 180 day group, with
no clear pattern suggesting remodelling with this marker of
plaque instability (Fig 3).
Relationship of plaque echomorphology with
histology. Histologic data were available from 65 patients
(plaques) after both echomorphologic assessment and ca-
rotid endarterectomy, of which 28 were designated unsta-
ble (16 rupture, 12 cap thinning) and 37 stable. The
median SLV-GSM was significantly lower in unstable
plaques vs stable plaques (15 [IQR, 4 to 31] vs 32 [IRQ, 17
to 48]; P  .01; Fig 4). A similar trend was seen for
MCSV-GSMmin (2 [IQR, 0 to 9] vs 11 [IQR, 4 to 16]; P
.008; Fig 5).
DISCUSSION
This cohort study is, to our knowledge, the first to
assess differences in carotid plaque echomorphology in
relation to the time since a neurologic event. We have
demonstrated changes in both global and focal plaque
echolucency within the first 180-day period after the pre-
senting neurologic symptom, which would be consistent
with plaque remodelling. Pathophysiologically, this is likely
to represent resorption of intraplaque hemorrhage, an in-
crease in plaque fibrous content, and a reduction in the
lipid/necrotic core. By contrast, no significant change was
noted in overall plaque heterogeneity during this period.
Surprisingly, plaques that were assessed 180 days
after the presenting symptom demonstrated features that
would suggest that they might have become less stable over
ellitus n (%) Hyperlipidemia n (%) Current smoker n (%)
15) 15 (75) 11 (55)
30) 7 (70) 1 (10)
6) 13 (81) 5 (31)
13) 9 (60) 5 (33)
16) 34 (79) 30 (70)
.69 0.01
e range for each subgroup
CSV-GSMmin P* MCSV-GSMmax-min P*
.95 (0.0-8.8) .004 30.2 (15.5-40.3) .08
6.5 (1.5-12.0) .17 28.0 (13.3-60.3) .20
7.0 (2.0-14.5) .09 32.0 (26.0-48.0) .01
5.3 (0.0-15.0) .042 28.0 (15.6-42.0) .15
3.4 (1.5-28.3) — 16.5 (8.0-30.8) —
ional views; GSMmin, lowest gray scale median; GSMmax-min, highest minusts
etes m
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1 (
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the findings of previous clinical studies that have confirmed
that the risk of stroke in such patients remains elevated for
up to 3 years.1,2 No differences were found in patient
demographics, degree of stenosis or the type of neurologic
Fig 1. Comparison of plaque SLV-GSM with time since a neuro-
logic event (P vs asymptomatic; Mann-Whitney test). SLV, Single
longitudinal view; GSM, gray scale median.
Fig 2. Comparison of plaque MCSV-GSMmin with time since a
neurologic event (P vs asymptomatic; Mann-Whitney test)MCSV,
multiple cross-sectional views; GSMmin, lowest gray scale median.
Fig 3. Comparison of plaque heterogeneity (MCSV-GSMmax-min)
with time since a neurological event (P versus asymptomatic;
Mann-Whitney).MCSV,Multiple cross-sectional views;GSMmax-min,
highest minus lowest gray scale median of cross-sectional views.symptoms between symptomatic groups to account forthese findings, although such a conclusion must remain
guarded owing to the small patient numbers in each
group.
Histologic differences between symptomatic and asymp-
tomatic plaques have been described previously, although
studies report conflicting results. Feeley et al4 examined
pathologic differences between 44 symptomatic and eight
asymptomatic plaques, demonstrating a reduction in colla-
gen/fibrous tissue in those causing symptoms (66% vs 88%
of plaque volume). They were unable to identify a relation-
ship between plaque structure and either the time since or
the number of neurologic events, leading them to conclude
Fig 4. Comparison of plaque SLV-GSM in unstable and stable
plaques on histology (P, Mann-Whitney). SLV, Single longitudinal
view; GSM, gray scale median. Data presented with mean, inter-
quartile range 95% interval.
Fig 5. Comparison of plaque MCSV-GSMmin in unstable and
stable plaques on histology (P, Mann-Whitney). Data presented
with mean, interquartile range 95% interval. MCSV, multiple
cross-sectional views; GSMmin, lowest gray scale median.that symptomatic plaques did not heal.4
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the European Carotid Plaque Study reported a reduction in
the “soft tissue” content of plaques examined 5 months
after symptoms.15 Although this would be consistent with
plaque remodelling, it might be that plaques with a lower
soft-tissue component were less likely to cause further
symptoms between the first neurologic episode and carotid
endarterectomy.
In a recent study assessing histology of 526 symptom-
atic carotid plaques in relation to nature and timing of
ischemic symptoms, plaques causing stroke were most un-
stable immediately after the neurologic event, with the
prevalence of plaque rupture and instability falling to pla-
teau levels at approximately 90 to 100 days. Interestingly,
cap rupture, inflammation, and instability in plaques caus-
ing TIAs was a less common feature immediately after
symptoms, and the prevalence did not change with time
since the neurologic event.16 These findings of possible
histologic remodelling in plaques causing recent stroke
would be in keeping with the echomorphologic changes
seen within the first 180 days after a neurologic event in this
study.
Echomorphologic assessment of carotid plaques was
first described in 1983, demonstrating the association be-
tween plaque heterogeneity, intraplaque hemorrhage, and
recent symptoms.17 A more detailed classification of SLV
plaque echomorphology was proposed in 198918; how-
ever, the subjectivity of this technique, associated with
changes in plaque echomorphology with both symptom-
atology and degree of stenosis,19,20 has led to conflicting
results in the literature.
The introduction of computer-assisted echomorpho-
logic assessment,21 particularly when combined with gray
scale normalization,22 has led to acceptable reproducibility
in both single longitudinal23 and multiple cross-sectional12
views. Further, differences in the B-mode ultrasound GSM
of various tissue components have been demonstrated24,25
and associated with specific histologic features in carotid
plaques.24-26
It must be emphasized that this is a cohort study with a
relatively small number of plaques in each group. Despite
this, the results are of considerable interest. Maximal differ-
ences in plaque echomorphology between asymptomatic
and symptomatic plaques occur in the first 30 days after a
neurologic event and persist to a lesser degree for up to 90
days. The assumption that such differences reflect plaque
instability would be entirely consistent with epidemiologic
evidence that demonstrates a higher risk of a second neu-
rologic event closely following the presenting symptom.3 It
further supports the findings of the Imaging in Carotid
Angioplasty and Risk of Stroke study, which reported that
plaques with a low SLV-GSM (25) are more likely to have
an adverse outcome from carotid angioplasty and stent-
ing,27 consistent with an increased risk of embolization
from unstable plaques.
The correlation between GSM and plaque histology in
this study, combined with data from two large histologic
studies,15,16 supports the concept of plaque remodelling toa more stable configuration with increasing time after an
ischemic neurologic event. No longitudinal echomorpho-
logic data are available to confirm these findings, however,
and this type of study would now be considered unethical.
Alternatively, it is possible that plaques with a more
stable configuration are less likely to cause recurrent symp-
toms, which might lead to a longer time interval between
the initial event and ultrasound assessment. There was no
evidence that this was the case in the current study, and the
finding of maximal instability immediately after an event
with a stepwise return to a more stable configuration over
the following 90 days would favor true plaque stabilization.
A final, important research question to address is the
timescale of changes in asymptomatic plaque echomor-
phology before a neurologic event in those that become
symptomatic. The Asymptomatic Carotid Surgery Trial
indicates that some 11% of asymptomatic plaques become
symptomatic by the end of a 5-year period.28 A longitudi-
nal study of plaque echomorphology, particularly MCSV-
GSMmin in patients with an asymptomatic 70% stenosis,
would be of considerable interest.
CONCLUSION
This cohort study has demonstrated interesting differ-
ences in GSM plaque echomorphology with time after the
most recent neurologic symptom in patients with symp-
tomatic carotid disease. The results raise some important
questions with respect to identifying currently asymptom-
atic patients whomight be at greatest risk of a TIA or stroke
and add to the debate concerning the relative risk/benefit
of carotid endarterectomy or CAS in recently symptomatic
patients.
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